Výsledky vyhledávání - "N. G. Tyurina"

Akademický článek

THE THYMIDINE KINASE-1(TK-1) AS A POTENTIAL TUMOR MARKER: SERUM LEVELS IN SERUM OF PATIENTS WITH SOLID AND SYSTEM MALIGNANCE NEOPLASMS

Autor: N. S. Sergeeva, N. K. Parilova, N. V. Marshutina, N. G. Tyurina, A. G. Mustafin

Publikováno v: Issledovaniâ i Praktika v Medicine, Vol 4, Iss 1, Pp 49-57 (2017)

The review summarizes the results of studies of levels and/or activity in the blood serum of a metabolic marker thymidine kinase-1 (TK-1) of proliferating cells in patients with lymphoproliferative diseases (LPD) and malignant neopasms (NM).Compariso

Externí odkaz: https://doaj.org/article/5aea3256e96e4063a8594d108c41c658

Zobrazit plný text záznamu

Akademický článek

The optimal time for hematopoietic stem cell translantation for Hodgkin's lymphoma. International guidelines and real practic in Russia and former USSSR countries (Part II)

Autor: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, Ye. A. Demina, N. G. Tyurina, M. A. Vernyuk, Ye. Ye. Karamanesht, A. G. Rumyantsev

Publikováno v: Онкогематология, Vol 9, Iss 3, Pp 32-40 (2015)

The influence of previous antitumor therapy the efficacy and tolerability of high-dose chemotherapy with autologous hematopoietic progenitor cells transplantation (HCST) in 369 patients with Hodgkin, s lymphoma in the clinics of Russia and CIS countr

Externí odkaz: https://doaj.org/article/9e6e7f17fa354ebf9f9c5a8190d253ae

Zobrazit plný text záznamu

Akademický článek

The optimal time for autologous hematopoietic progenitor cell transplantation during treatment of Hodgkin's lymphoma. Foreign recommendations and russian experience

Autor: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, N. G. Tyurina, M. A. Vernyuk, E. E. Karamanesht, A. G. Rumyantsev

Publikováno v: Онкогематология, Vol 9, Iss 2, Pp 37-44 (2014)

Autologous hematopoietic stem cell transplantation (HSCT) is the standard treatment for patients with relapsed and primary refractoryHodgkin's lymphoma (HL). According to current recommendations HSCT must be performed in first relapse or after regist

Externí odkaz: https://doaj.org/article/a6a5819cace74f079c937d2e1c275049

Zobrazit plný text záznamu

Akademický článek

Own experience of primary mediastinal B-large cell lymphoma treatment

Autor: M. A. Vernyuk, N. G. Tyurina, O. A. Pavlova, A. M. Chervontseva, N. V. Zhukov

Publikováno v: Онкогематология, Vol 8, Iss 4, Pp 18-23 (2014)

Due to the relative low incidence of primary mediastinal B-large cell lymphoma (PM BLCL) optimal approaches to its treatment is still not well developed. Possibility to improve PM BLCL clinical outcomes by intensifying induction chemotherapy (CT) and

Externí odkaz: https://doaj.org/article/92ced134509c4f979192382fbc36a309

Zobrazit plný text záznamu

Akademický článek

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients

Autor: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasyev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, E. E. Karamanesht, N. G. Tyurina, O. A. Pavlova, A. G. Rumyantsev, A. D. Kaprin

Publikováno v: Онкогематология, Vol 8, Iss 3, Pp 35-41 (2014)

Traditionally, the concern of fatal complication is a major obstacle to transfer patients with unfavorable course of Hodgkin’s lymphoma tonational transplantation centers. Early mortality after high-dose chemotherapy with autologous hematopoietic s

Externí odkaz: https://doaj.org/article/f6115523b8514ec88678b6e2d7768b68

Zobrazit plný text záznamu

Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

Autor: I. S. Meisner, N. K. Parilova, N. V. Marshutina, N. G. Tyurina, N. S. Sergeeva

Publikováno v: Kliničeskaâ onkogematologiâ, Vol 9, Iss 1, Pp 6-12 (2016)

Background & Aims. Lactate dehydrogenase (LDH) and b2-microglobulin (b2-MG) are usually detected as serological tumor markers (TM) in malignant lymphoproliferative diseases (LPD); however, their use in monitoring of chemotherapy (CT) is limited due t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::257c0739fb0d69f378653332c0af2261
https://doi.org/10.21320/2500-2139-2016-9-1-6-12

Zobrazit plný text záznamu

[The complex morphologic diagnostic of marginal zone lymphoma.]

Autor: E N, Slavnova, N G, Tyurina, S T, Golovin, A N, Petrov

Publikováno v: Klinicheskaia laboratornaia diagnostika. 62(8)

The purpose of study: To determine possibilities of complex morphological diagnostic (routine cytology and histology, immunocytochemistry and immunohistochemistry, molecular genetics) of lymphoma of marginal zone. The study included 10 patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::94006946ccc230faeba91953e8e64018
https://pubmed.ncbi.nlm.nih.gov/30802397

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání